We are live on
!
Find out more
THSP
Taube Hodson Stonex Partners Portfolio holdings
AUM
$488M
1-Year Est. Return
4.7%
This Fund
S&P 500
This Quarter
Est. Return
-2.58%
1 Year Est. Return
-4.7%
3 Year Est. Return
+8.82%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
–
Cap. Flow
+$1.04B
Cap. Flow
% of AUM
102.16%
Top 10 Holdings %
Top 10 Hldgs %
75.99%
Holding
16
New
16
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$119M |
| 2 |
PepsiCo
PEP
|
+$95.5M |
| 3 |
Transocean
RIG
|
+$90.6M |
| 4 |
Mondelez International
MDLZ
|
+$78M |
| 5 |
Intuit
INTU
|
+$74.9M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 22.11% |
| 2 | Energy | 16.19% |
| 3 | Healthcare | 15.69% |
| 4 | Technology | 13.48% |
| 5 | Industrials | 7.57% |
Similar funds
JWCA
ICAS
ACM
TT
WA
FVFIGP
ZA
VFS
Taube Hodson Stonex Partners's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Taube Hodson Stonex Partners, which disclosed 16 positions worth $1.02B. Its ten largest holdings account for 76% of the portfolio.
Its largest position is Pfizer: 4,303,944 shares worth $114M.
By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, followed by Energy and Healthcare.
- Taube Hodson Stonex Partners's largest Q2 2013 buy was Pfizer: 4,303,944 shares worth $114M.
- Taube Hodson Stonex Partners's ten largest holdings make up 76% of its $1.02B portfolio in Q2 2013.
- Taube Hodson Stonex Partners disclosed 16 positions in Q2 2013, its first 13F filing on record.
Based on Taube Hodson Stonex Partners's 13F filing for Q2 2013, filed 18 Jul 2013.